Funder
U.S. Department of Health & Human Services | National Institutes of Health
National Science Foundation
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases
Publisher
Springer Science and Business Media LLC
Reference54 articles.
1. Scott, D. L., Smith, C. & Kingsley, G. Joint damage and disability in rheumatoid arthritis: an updated systematic review. Clinical and experimental rheumatology 21, S20–27 (2003).
2. Gibofsky, A. Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. The American journal of managed care 18, S295–302 (2012).
3. Lipsky, P. E. Are new agents needed to treat RA? Nat Rev Rheumatol 5, 521–522 (2009).
4. van Steenbergen, H. W., da Silva, J. A. P., Huizinga, T. W. J. & van der Helm-van Mil, A. H. M. Preventing progression from arthralgia to arthritis: targeting the right patients. Nature reviews. Rheumatology 14, 32–41,
https://doi.org/10.1038/nrrheum.2017.185
(2018).
5. Singh, J. A. et al. Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis care & research 64, 625–639,
https://doi.org/10.1002/acr.21641
(2012).
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献